Skip to content
HomeLatest newsCaring & giving5 things to know about how Johnson & Johnson is helping kids with intestinal worms

5 things to know about how Johnson & Johnson is helping kids with intestinal worms

For World Neglected Tropical Diseases Day, check out a video highlighting the company’s commitment to caring for children with these common infections across the globe.

Share Article
share to

In 2012, Johnson & Johnson joined other pharmaceutical companies and organizations, including the Bill & Melinda Gates Foundation, to endorse the London Declaration on Neglected Tropical Diseases (NTDs). As part of this commitment, companies pledged to donate existing treatments—such as mebendazole, Johnson & Johnson’s medicine for soil-transmitted helminths (STH), or intestinal worm infections—and develop new tools to help combat these infections.

STH infections are among the most common infections around the globe and result from being exposed to contaminated soil, food or water in areas with poor sanitation. Children are particularly vulnerable to the infection, which can lead to malnutrition, stunted growth and even impaired cognitive development.

To help protect kids ages 1 and older against the infection, the Janssen Pharmaceutical Companies of Johnson & Johnson developed a chewable formulation of mebendazole that, when mixed with a small amount of water, turns into a soft mass and is easier for very young children to swallow.

Ten years after the landmark London Declaration, here’s a look at how the company is ensuring that mebendazole is accessible to those who need it.

5 Things to Know About How Johnson & Johnson is Helping Kids With Intestinal Worms

Johnson & Johnson aims to advance health around the world

Read about more ways the company is helping to solve complex global health challenges, from HIV to Ebola.
Giving Back : Ebola

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.